Legend Biotech Corp (LEGN) stock
LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$16.25+0.14 (+0.87%)
Close on Nov 18, 2026Market cap $3.01BP/E –Yield –
Legend Biotech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Legend Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$89.40M. For fiscal 2025 it was -$100.20M. The highest annual figure on record is $307.68M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$100.20M | – |
| FY2024 | Dec 31, 2024 | -$144.00M | – |
| FY2023 | Dec 31, 2023 | -$393.30M | – |
| FY2022 | Dec 31, 2022 | -$201.28M | – |
| FY2021 | Dec 31, 2021 | -$198.47M | – |
| FY2020 | Dec 31, 2020 | -$223.01M | – |
| FY2019 | Dec 31, 2019 | -$83.07M | -127.0% |
| FY2018 | Dec 31, 2018 | $307.68M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$20.90M | – |
| Q1 FY2026 | Mar 31, 2026 | -$85.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.21M | – |
| Q3 FY2025 | Sep 30, 2025 | $28.81M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.20M | – |
| Q1 FY2025 | Mar 31, 2025 | -$103.60M | -767.6% |
| Q4 FY2024 | Dec 31, 2024 | -$82.05M | – |
| Q3 FY2024 | Sep 30, 2024 | -$75.82M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.65M | – |
| Q1 FY2024 | Mar 31, 2024 | $15.52M | – |
| Q4 FY2023 | Dec 31, 2023 | -$95.67M | – |
| Q3 FY2023 | Sep 30, 2023 | -$60.85M | – |
| Q2 FY2023 | Jun 30, 2023 | -$97.57M | – |
| Q1 FY2023 | Mar 31, 2023 | -$139.22M | – |
| Q4 FY2022 | Dec 31, 2022 | -$49.74M | – |
| Q3 FY2022 | Sep 30, 2022 | -$72.11M | – |
See a number that looks wrong?